Attend The Society of Thoracic Surgeons鈥� 2025 Annual Meeting, featuring late-breaking scientific research, thought-provoking lectures, cutting-edge technologies, and innovative cardiothoracic surgery products, January 24 鈥� January 26, in Los Angeles.
The Society of Thoracic Surgeons Launches New Thoracic Surgery Risk Calculators
The expanding use of transcatheter technologies has changed the landscape in the treatment of valvular disease in adult cardiac patients, with valve surgery rapidly shifting to more complex interventions frequently involving other concomitant procedures.
The first annual STS Cardiothoracic Surgeon Compensation Report is now available to help US-based cardiothoracic surgeons understand their value and make informed career decisions using reliable benchmarks specific to the specialty.
Jennifer C. Romano, MD, a congenital heart surgeon at Congenital Heart Center/C. S. Mott Children's Hospital, and the Herbert Sloan Collegiate Professor of Cardiac Surgery at the University of Michigan Medical School, was elected president of The Society of Thoracic Surgeons today at STS 2024 during the Society鈥檚 Business Meeting.
In patients who undergo pulmonary resection for lung cancer, a major potential postoperative complication is venous thromboembolism (VTE)鈥攁 condition that develops when a blood clot forms in a vein鈥攚hich can lead to part of the clot breaking off and lodging in the lung, resulting in a pulmonary embolism (PE).
A study of pediatric heart surgery centers across the United States has demonstrated that, when it comes to successful surgery, it鈥檚 not just the size of the program that matters in determining quality outcomes.
In a study presented at The Society of Thoracic Surgeons鈥� 2024 Annual Meeting in San Antonio, Texas, researchers examined outcomes for patients undergoing SAVR and those undergoing TAVR from 2013 to 2021 in the state of California.
A new study presented at The Society of Thoracic Surgeons鈥� 2024 Annual Meeting in San Antonio, Texas, examines the ongoing controversy surrounding the choice between multi-arterial grafting (MAG) and single arterial grafting (SAG) in coronary artery bypass grafting (CABG) for multivessel coronary revascularization.
The Society of Thoracic Surgeons has released late-breaking research scheduled for presentation at the 2024 Annual Meeting taking place January 27 - 29 in San Antonio.
Credentialed press representatives are invited to attend The Society of Thoracic Surgeons鈥� 60th Annual Meeting, featuring late-breaking scientific research, thought-provoking lectures, cutting-edge technologies, and innovative cardiothoracic surgery products.
A study published today in The Annals of Thoracic Surgery demonstrates outstanding long-term survival following low-risk isolated surgical aortic valve replacement (SAVR)
The Society of Thoracic Surgeons has launched its next-generation Operative Risk Calculator to assess the risk of adult cardiac surgery operations.
The Society of Thoracic Surgeons has launched a new risk calculator to estimate the risk of mitral valve repair for patients with mitral valve prolapse and degenerative primary mitral regurgitation.
Cardiothoracic surgeon Thomas E. MacGillivray, MD, from MedStar Health, was elected President of The Society of Thoracic Surgeons at STS 2023 during the Society鈥檚 Business Meeting.
A study of more than 100,000 patients has revealed that, for patients with blockages in multiple arteries, those who opt for coronary artery bypass grafting (CABG) are less likely to die from their condition, less likely to need additional surgery, and less likely to have a heart attack than patients who choose to undergo a stent procedure.
Identifying and closing gaps and disparities in health care subject of scientific session at the 59th Annual Meeting of The Society of Thoracic Surgeons.
In an article published jointly on January 18, 2023, in both The Annals of Thoracic Surgery and the Journal of the American College of Cardiology, leading cardiology and cardiothoracic surgical researchers analyzed recent national data to assess the outcomes and risk of mitral valve repair for primary mitral regurgitation.
Credentialed press representatives are invited to attend The Society of Thoracic Surgeons鈥� 59th Annual Meeting and Exhibition, which will include late-breaking scientific research, thought-provoking lectures, cutting-edge technologies, and innovative cardiothoracic surgery products.
Some patients with severe COVID-19 who are treated with extracorporeal membrane oxygenation (ECMO) may experience significant lung recovery and return to normal lives with 鈥渕eaningful鈥� long-term outcomes.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal 麻豆传媒 keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right